These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9527404)

  • 21. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis.
    Rashid G; Korzets Z; Bernheim J
    Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cartilage biomarkers in hemodialysis patients and the effect of beta2-microglobulin on articular chondrocytes.
    Sunk IG; Demetriou D; Szendroedi J; Amoyo L; Raffetseder A; Hörl WH; Sunder-Plassmann G; Smolen JS; Bobacz K
    Osteoarthritis Cartilage; 2008 Nov; 16(11):1336-42. PubMed ID: 18457963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of beta 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum.
    Niwa T; Katsuzaki T; Momoi T; Miyazaki T; Ogawa H; Saito A; Miyazaki S; Maeda K; Tatemichi N; Takei Y
    Kidney Int; 1996 Mar; 49(3):861-7. PubMed ID: 8648931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis.
    Fujimoto N; Yajima M; Ohnishi Y; Tajima S; Ishibashi A; Hata Y; Enomoto U; Konohana I; Wachi H; Seyama Y
    J Invest Dermatol; 2002 Mar; 118(3):479-84. PubMed ID: 11874487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of advanced glycation end-products and aminoguanidine on TNFalpha production by rat peritoneal macrophages.
    Rashid G; Luzon AA; Korzets Z; Klein O; Zeltzer E; Bernheim J
    Perit Dial Int; 2001; 21(2):122-9. PubMed ID: 11330554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating level of alpha2-macroglobulin-beta2-microglobulin complex in hemodialysis patients.
    Motomiya Y; Ando Y; Haraoka K; Sun X; Iwamoto H; Uchimura T; Maruyama I
    Kidney Int; 2003 Dec; 64(6):2244-52. PubMed ID: 14633149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes.
    Cartledge JJ; Eardley I; Morrison JF
    BJU Int; 2001 Mar; 87(4):402-7. PubMed ID: 11251537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis.
    Giorgetti S; Stoppini M; Tennent GA; Relini A; Marchese L; Raimondi S; Monti M; Marini S; Østergaard O; Heegaard NH; Pucci P; Esposito G; Merlini G; Bellotti V
    Protein Sci; 2007 Feb; 16(2):343-9. PubMed ID: 17242436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of advanced glycation end products by aminoguanidine restores mast cell numbers and reactivity in alloxan-diabetic rats.
    Carvalho VF; Florim LT; de O Barreto E; Torres RC; Batista MM; Amendoeira FC; Cordeiro RS; Martins MA; E Silva PM
    Eur J Pharmacol; 2011 Nov; 669(1-3):143-8. PubMed ID: 21864526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation end products in Descemet's membrane and their effect on corneal endothelial cell.
    Kaji Y; Amano S; Usui T; Suzuki K; Tanaka S; Oshika T; Nagai R; Horiuchi S
    Curr Eye Res; 2001 Dec; 23(6):469-77. PubMed ID: 12045898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.
    Miyata T; Hori O; Zhang J; Yan SD; Ferran L; Iida Y; Schmidt AM
    J Clin Invest; 1996 Sep; 98(5):1088-94. PubMed ID: 8787669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Filtration of native and glycated beta2-microglobulin by charged and neutral dialysis membranes.
    Randoux C; Gillery P; Georges N; Lavaud S; Chanard J
    Kidney Int; 2001 Oct; 60(4):1571-7. PubMed ID: 11576375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking.
    Brownlee M; Vlassara H; Kooney A; Ulrich P; Cerami A
    Science; 1986 Jun; 232(4758):1629-32. PubMed ID: 3487117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effect of different inhibitors of the non-enzymatic glycation of rat tail tendons and bovine serum albumin.
    Menzel EJ; Reihsner R
    Ann Clin Biochem; 1996 May; 33 ( Pt 3)():241-8. PubMed ID: 8791988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.
    Soulis T; Cooper ME; Sastra S; Thallas V; Panagiotopoulos S; Bjerrum OJ; Jerums G
    Diabetologia; 1997 Oct; 40(10):1141-51. PubMed ID: 9349594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of a synthetic glucose derived advanced glycation end product that is immunologically cross-reactive with its naturally occurring counterparts.
    Al-Abed Y; Bucala R
    Bioconjug Chem; 2000; 11(1):39-45. PubMed ID: 10639083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gold Nanoparticle-Bioconjugated Aminoguanidine Inhibits Glycation Reaction: An
    Ahmad S; Khan MS; Alouffi S; Khan S; Khan M; Akashah R; Faisal M; Shahab U
    Biomed Res Int; 2021; 2021():5591851. PubMed ID: 34055984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dialysis-related spinal canal stenosis: a clinicopathological study on amyloid deposition and its AGE modification.
    Nokura K; Koga H; Yamamoto H; Kimura A; Tamai H; Yazaki S; Suzuki N; Miyazaki S; Niwa T
    J Neurol Sci; 2000 Sep; 178(2):114-23. PubMed ID: 11018703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoguanidine inhibits protein browning without extensive Amadori carbonyl blocking.
    Requena JR; Vidal P; Cabezas-Cerrato J
    Diabetes Res Clin Pract; 1993 Jan; 19(1):23-30. PubMed ID: 8472617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased formation of advanced glycation end-products in peritoneal fluid by carnosine and related peptides.
    Alhamdani MS; Al-Azzawie HF; Abbas FK
    Perit Dial Int; 2007; 27(1):86-9. PubMed ID: 17179517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.